- Home
- Products
- Customized ADCs
- TNFRSF17
- Anti-TNFRSF17 (clone CA8 J8M1)-Mc-MMAF ADC
Anti-TNFRSF17 (clone CA8 J8M1)-Mc-MMAF ADC (CAT#: ADC-W-285)
This ADC product is comprised of an anti-TNFRSF17 monoclonal antibody (clone J8M1) conjugated via a Mc linker to MMAF. The MMAF is targeted to certain cancers by immunerecognition and delivered into cancer cells via receptor mediated endocytosis. Within the cell, MMAF binds to tubulins, interrupts microtubule dynamics, and subsequently, induces cell death.
- Product Information
- ADC Target
- ADC Antibody
- ADC Linker
- ADC payload drug
- Antibody clone #
- CA8 J8M1
- Name
- TNFRSF17
- Alternative Names
- TNFRSF17; tumor necrosis factor receptor superfamily, member 17; BCM; BCMA; CD269; TNFRSF13A; tumor necrosis factor receptor superfamily member 17; B-cell maturation factor; B cell maturation antigen; B-cell maturation protein;
- Target Entrez Gene ID
- 608
- Target UniProt ID
- Q02223
- Overview
- The protein encoded by this gene is a member of the TNF-receptor superfamily. This receptor is preferentially expressed in mature B lymphocytes, and may be important for B cell development and autoimmune response. This receptor has been shown to specifically bind to the tumor necrosis factor (ligand) superfamily, member 13b (TNFSF13B/TALL-1/BAFF), and to lead to NF-kappaB and MAPK8/JNK activation. This receptor also binds to various TRAF family members, and thus may transduce signals for cell survival and proliferation.
- Overview
- Humanized Anti-TNFRSF17 antibody, clone # CA8 J8M1
- Clone #
- CA8 J8M1
- Species Reactivity
- Human
- Name
- Mc (maleimidocaproyl)
- Description
- Noncleavable linkers, is considered noncleavable-meaning linker cleavage, and payload release does not depend on the differential properties between the plasma and some cytoplasmic compartments. Instead, the release of the cytotoxic drug is postulated to occur after internalization of the ADC via antigen-mediated endocytosis and delivery to lysosomal compartment, where the antibody is degraded to the level of amino acids through intracellular proteolytic degradation.
- Name
- MMAF (Monomethyl auristatin F)
- Description
- Derived from Auristatin,are water-soluble dolastatin analogs of dolastatin 10. Dolastatin 10 belongs to dolastatin family and it can powerfully bind to tubulin, thus inhibiting polymerization mediated through the binding to the vinca alkaloid binding domain, and causes cell to accumulate in metaphase arrest.
For Research Use Only. NOT FOR CLINICAL USE.
Related Products
- Anti-MUC1 (clone ch3A5)-Mc-MMAF ADC (CAT#: ADC-W-240)
- Anti-CEACAM1 (clone T84.66) scFv-dextran T-40-MMC ADC (CAT#: ADC-W-381)
- Anti-DLL3 (clone SC16.15)-PBD dimers ADC (CAT#: ADC-W-102)
- Anti-C-kit (NEG087)-SMCC-DM1 ADC (CAT#: ADC-W-074)
- Anti-VEGFA (Bevacizumab)-SMCC-DM1 ADC (CAT#: ADC-W-1928)
- Anti-CD79B (Polatuzumab)-VC-MMAE ADC (CAT#: ADC-W-379)
- Anti-IGHE (Ligelizumab)-SPDB-DM4 ADC (CAT#: ADC-W-1281)
- Anti-AOC3 (Vepalimomab)-SPDB-DM4 ADC (CAT#: ADC-W-675)
- Anti-KDR (Ramucirumab)-SPDB-DM4 ADC (CAT#: ADC-W-1515)
- Anti-ERBB2 (Trastuzumab)-SPDP-KG6E-AF ADC (CAT#: ADC-W-407)
Published Data
+ Submit Publications
Scientific Resources
Customer Reviews and FAQs
There are currently no Customer reviews or questions for ADC-W-285. Click the button above to contact us or submit your feedback about this product.
Quick Links
Other Products
Same Target
Same Linker
Same Payload
| CAT# | Product Name | Linker | Payload |
| ADC-W-278 | Anti-TNFRSF17 (clone CA8 J6M0)-Mc-MMAF ADC | Mc (maleimidocaproyl) | MMAF (Monomethyl auristatin F) |
| ADC-W-289 | Anti-TNFRSF17 (clone CA8 J9M2)-Mc-MMAF ADC | Mc (maleimidocaproyl) | MMAF (Monomethyl auristatin F) |
| ADC-W-277 | Anti-TNFRSF17 (clone CA8 J9M2)-VC-MMAE ADC | VC (valine-citrulline) | MMAE (Monomethyl auristatin E) |
| ADC-W-283 | Anti-TNFRSF17 (clone CA8 J7M2)-Mc-MMAF ADC | Mc (maleimidocaproyl) | MMAF (Monomethyl auristatin F) |
| ADC-W-284 | Anti-TNFRSF17 (clone CA8 J8M0)-Mc-MMAF ADC | Mc (maleimidocaproyl) | MMAF (Monomethyl auristatin F) |
| CAT# | Product Name | Linker | Payload |
| ADC-W-2612 | Anti-MS4A1 (Rituximab)-MC-MMAF ADC | MC (maleimidocaproyl) | MMAF |
| ADC-W-485 | Anti-EphA2 (clone 1C1)-Mc-MMAF ADC | Mc (maleimidocaproyl) | MMAF (Monomethyl auristatin F) |
| ADC-W-493 | Anti-CD19 (clone huB4)-Mc-MMAF ADC | Mc (maleimidocaproyl) | MMAF (Monomethyl auristatin F) |
| ADC-W-115 | Anti-CD33 (clone h2H12)-Mc-MMAF ADC | Mc (maleimidocaproyl) | MMAF (Monomethyl auristatin F) |
| ADC-W-114 | Anti-CD33 (clone m2H12)-Mc-MMAF ADC | Mc (maleimidocaproyl) | MMAF (Monomethyl auristatin F) |
| CAT# | Product Name | Linker | Payload |
| ADC-AA-001 | anti-HIgG(Fc)-N-MMAF ADC | Noncleavable linkers | MMAF (Monomethyl auristatin F) |
| ADC-W-604 | Anti-FUT3 (clone BR96)-Mc-VC-PABC-MMAF ADC | MC-VC-PABC (maleimidocaproyl-valine-citrulline-p-aminobenzoyloxycarbonyl) | MMAF (Monomethyl auristatin F) |
| ADC-AA-010 | anti-HIgG(Fc)Fab-C-MMAF ADC | Cleavable linkers | MMAF (Monomethyl auristatin F) |
| ADC-AA-019 | anti-MIgG(Fc)-N-MMAF ADC | Noncleavable linkers | MMAF (Monomethyl auristatin F) |
| ADC-W-493 | Anti-CD19 (clone huB4)-Mc-MMAF ADC | Mc (maleimidocaproyl) | MMAF (Monomethyl auristatin F) |
Online Inquiry
Welcome! For price inquiries, please feel free to contact us through the form on the left side. We will get back to you as soon as possible.
